{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:20:31Z","timestamp":1792592431647,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000142","name":"Avon Foundation for Women","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000142","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lymphedema is a common complication of breast cancer treatment that affects one in five breast cancer survivors, yet there is no reliable method to detect lymphedema in the subclinical range. The objective of this study was to determine the feasibility and reliability of using an infrared 3D scanning device (ISD) as a peri-operative limb volume measurement tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Fifteen patients were analyzed based on inclusion criteria. Peri-operative measurements were obtained using tape measure and an ISD. Volumes were calculated using a standard algorithm for tape measure and a custom algorithm for ISD measurements. Linear regression models were used to assess ISD and tape measurement volume and circumference correlation. One-way ANOVA was used to compare change in percent difference at set time points post-operatively (2\u20133 weeks, 4\u20136 weeks, and 7\u201312 weeks) for both ISD and tape measure.\n                      <jats:italic>t<\/jats:italic>\n                      tests for unequal variances with the Bonferroni correction were performed among these groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There is a positive linear correlation (\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 0.8518) between absolute volume measurements by the ISD and tape measure. Analyses over 2\u201310 weeks post-operatively showed that the ISD was able to detect volume changes in both the unaffected and the affected arm. Furthermore, the affected arm tended to have a greater increase in volume in the majority of patients, indicating these patients could be at risk for lymphedema.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Technology utilizing infrared 3D scanners can reliably measure limb volume pre- and post-treatment similarly to tape measure in a small sample of patients. Further research using 3D scanning technology with a longer follow up is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-020-02043-y","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T16:13:57Z","timestamp":1603815237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["An infrared 3D scanning device as a novel limb volume measurement tool in breast cancer patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Bernadette N.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris M.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeslieAnn S.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Brandon","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan D.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Binkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Subhedar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Okoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Buhariwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Suarez-Ligon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2397-5949","authenticated-orcid":false,"given":"Sheryl G. A.","family":"Gabram-Mendola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"2043_CR1","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program, Research Data (1973-2013), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch. Cancer Stat Facts: Female Breast Cancer. Available from URL: https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html [accessed 9\/29\/2020)."},{"key":"2043_CR2","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1200\/JCO.2007.12.3075","volume":"26","author":"AL Cheville","year":"2008","unstructured":"Cheville AL, Troxel AB, Basford JR, Kornblith AB. Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. J Clin Oncol. 2008;26:2621\u20139.","journal-title":"J Clin Oncol"},{"key":"2043_CR3","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.ijrobp.2011.05.043","volume":"81","author":"C Shah","year":"2011","unstructured":"Shah C, Vicini FA. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. Int J Radiat Oncol Biol Phys. 2011;81:907\u201314.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2043_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14:500\u201315.","journal-title":"Lancet Oncol"},{"key":"2043_CR5","unstructured":"Hayes SC, Janda M, Cornish BH, Battistutta D, Newman B. Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology. 2008;41:18\u201328. https:\/\/journals.uair.arizona.edu\/index.php\/lymph\/article\/view\/17060. Accessed 29 Sept 2020."},{"key":"2043_CR6","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9","volume":"92","author":"JA Petrek","year":"2001","unstructured":"Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368\u201377.","journal-title":"Cancer."},{"issue":"6","key":"2043_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1055\/s-0036-1572538","volume":"32","author":"TR Penha","year":"2016","unstructured":"Penha TR, Botter B, Heuts EM, Voogd AC, von Meyenfeldt MF, van der Hulst RR. Quality of life in patients with breast cancer-related lymphedema and reconstructive breast surgery. J Reconstr Microsurg. 2016;32(6):484\u201390.","journal-title":"J Reconstr Microsurg"},{"key":"2043_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1053\/sonc.2000.8117","volume":"16","author":"MM Hull","year":"2000","unstructured":"Hull MM. Lymphedema in women treated for breast cancer. Semin Oncol Nurs. 2000;16:226\u201337.","journal-title":"Semin Oncol Nurs"},{"key":"2043_CR9","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/pon.3201","volume":"22","author":"MR Fu","year":"2013","unstructured":"Fu MR, Ridner SH, Hu SH, Stewart BR, Cormier JN, Armer JM. Psychosocial impact of lymphedema: a systematic review of literature from 2004-2011. Psychooncology. 2013;22:1466\u201384.","journal-title":"Psychooncology."},{"key":"2043_CR10","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12B+<2817::AID-CNCR32>3.0.CO;2-2","volume":"83","author":"SD Passik","year":"1998","unstructured":"Passik SD, McDonald MV. Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer. 1998;83:2817\u201320.","journal-title":"Cancer."},{"key":"2043_CR11","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1200\/JCO.2008.18.3517","volume":"27","author":"XY Shih Y-CT","year":"2009","unstructured":"Shih Y-CT XY, Cormier JN, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27:2007\u201314.","journal-title":"J Clin Oncol"},{"key":"2043_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1081\/CNV-48707","volume":"23","author":"JM Armer","year":"2005","unstructured":"Armer JM. The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Investig. 2005;23:76\u201383.","journal-title":"Cancer Investig"},{"key":"2043_CR13","first-page":"161","volume":"42","author":"JN Cormier","year":"2009","unstructured":"Cormier JN, Xing Y, Zaniletti I, Askew RL, Stewart BR, Armer JM. Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology. 2009;42:161\u201375 https:\/\/journals.uair.arizona.edu\/index.php\/lymph\/article\/view\/17073.","journal-title":"Lymphology."},{"key":"2043_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00520-018-4334-7","volume":"27","author":"JM Armer","year":"2019","unstructured":"Armer JM, Ballman KV, McCall L, et al. Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons oncology group (ACOSOG) Z1071 (Alliance) substudy. Support Care Cancer. 2019;27:495\u2013503.","journal-title":"Support Care Cancer"},{"key":"2043_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12609-013-0105-0","volume":"5","author":"JM Armer","year":"2013","unstructured":"Armer JM, Hulett JM, Bernas M, Ostby P, Stewart BR, Cormier JN. Best practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Curr Breast Cancer Rep. 2013;5:134\u201344.","journal-title":"Curr Breast Cancer Rep"},{"key":"2043_CR16","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/cncr.23494","volume":"112","author":"NL Stout Gergich","year":"2008","unstructured":"Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112:2809\u201319.","journal-title":"Cancer."},{"key":"2043_CR17","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/cncr.27476","volume":"118","author":"NL Stout","year":"2012","unstructured":"Stout NL, Binkley JM, Schmitz KH, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012;118:2191\u2013200.","journal-title":"Cancer."},{"key":"2043_CR18","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1245\/s10434-016-5315-z","volume":"23","author":"L Lai","year":"2016","unstructured":"Lai L, Binkley J, Jones V, et al. Implementing the prospective surveillance model (psm) of rehabilitation for breast cancer patients with 1-year postoperative follow-up, a prospective, observational study. Ann Surg Oncol. 2016;23:3379\u201384.","journal-title":"Ann Surg Oncol"},{"key":"2043_CR19","first-page":"228","volume-title":"A kinect-based system to assess lymphedema impairments in breast cancer patients","author":"R Moreira","year":"2015","unstructured":"Moreira R, Magalh\u00e3es A, Oliveira HP. A kinect-based system to assess lymphedema impairments in breast cancer patients. Cham: Springer International Publishing; 2015. p. 228\u201336."},{"key":"2043_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s10278-019-00183-6","volume":"32","author":"EJ Speir","year":"2019","unstructured":"Speir EJ, Matthew Hawkins C, Weiler MJ, et al. Volumetric assessment of pediatric vascular malformations using a rapid, hand-held three-dimensional imaging system. J Digit Imaging. 2019;32:260\u20138.","journal-title":"J Digit Imaging"},{"key":"2043_CR21","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.4269\/ajtmh.17-0504","volume":"97","author":"C Yahathugoda","year":"2017","unstructured":"Yahathugoda C, Weiler MJ, Rao R, et al. Use of a novel portable three-dimensional imaging system to measure limb volume and circumference in patients with filarial lymphedema. Am J Trop Med Hyg. 2017;97:1836\u201342.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"2043_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/ptj\/pzz175","volume":"100","author":"JM Binkley","year":"2020","unstructured":"Binkley JM, Weiler MJ, Frank N, Bober L, Dixon JB, Stratford PW. Reliability and convergent validity of the lymphatech system to assess arm volume in patients during and after treatment for breast cancer. Phys Ther. 2020;100(3):457\u201367.","journal-title":"Phys Ther"},{"key":"2043_CR23","unstructured":"Mayrovitz HN. Limb volume estimates based on limb elliptical vs. circular cross section models. Lymphology. 2003;36:140-3. https:\/\/journals.uair.arizona.edu\/index.php\/lymph\/article\/view\/17243. Accessed 29 Sept 2020."},{"key":"2043_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/ptj\/86.2.205","volume":"86","author":"R Taylor","year":"2006","unstructured":"Taylor R, Jayasinghe UW, Koelmeyer L, Ung O, Boyages J. Reliability and validity of arm volume measurements for assessment of lymphedema physical therapy. Phys Ther. 2006;86:205\u201314.","journal-title":"Phys Ther"},{"key":"2043_CR25","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/01.sap.0000257149.42922.7e","volume":"59","author":"AG Warren","year":"2007","unstructured":"Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema : a comprehensive review. Ann Plast Surg. 2007;59:464\u201372.","journal-title":"Ann Plast Surg"},{"key":"2043_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1200\/JOP.18.00141","volume":"15","author":"P Tandra","year":"2019","unstructured":"Tandra P, Kallam A, Krishnamurthy J. Identification and management of lymphedema in patients with breast cancer. Journal of Oncology Practice. 2019;15:255\u201362.","journal-title":"Journal of Oncology Practice"},{"key":"2043_CR27","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12B+<2798::AID-CNCR28>3.0.CO;2-E","volume":"83","author":"PS Mortimer","year":"1998","unstructured":"Mortimer PS. The pathophysiology of lymphedema. Cancer. 1998;83:2798\u2013802.","journal-title":"Cancer."},{"key":"2043_CR28","first-page":"118","volume":"43","author":"JM Armer","year":"2010","unstructured":"Armer JM, Stewart BR. Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology. 2010;43:118\u201327 https:\/\/journals.uair.arizona.edu\/index.php\/lymph\/article\/view\/17011.","journal-title":"Lymphology."},{"issue":"12","key":"2043_CR29","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.2522\/ptj.20150412","volume":"96","author":"JT Hidding","year":"2016","unstructured":"Hidding JT, Viehoff PB, Beurskens CH, et al. Measurement properties of insturments for measuring of lymphedema: systematic review. Phys Ther. 2016;96(12):1965\u201381.","journal-title":"Phys Ther"},{"issue":"10","key":"2043_CR30","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1245\/s10434-019-07344-5","volume":"26","author":"SH Ridner","year":"2019","unstructured":"Ridner SH, Dietrich MS, Cowher MS, et al. A randomized trial evaluating bioimpedance spectroscopy versus tape measurment for the prevention of lymphedema following treatment for breast cancer: interim analysis. Ann Surg Oncol. 2019;26(10):3250\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2043_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10549-015-3357-8","volume":"151","author":"NJ Bundred","year":"2015","unstructured":"Bundred NJ, Stockton C, Keeley V, et al. Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphedema after axillary node clearance for breast cancer. Breast Cancer Res Treat. 2015;151(1):121\u20139.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"2043_CR32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.bjps.2018.02.012","volume":"71","author":"ES Qin","year":"2018","unstructured":"Qin ES, Bowen MJ, Chen WF. Diagnostic accuracy of bioimpedance spectroscopy in patients with lymphedema: a retrospective cohort analysis. J Plast Reconstr Aesthet Surg. 2018;71(7):1041\u201350.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2043_CR33","doi-asserted-by":"crossref","unstructured":"Polomska AK, Proulx ST: Imaging technology of the lymphatic system. Advanced Drug Delivery Reviews. On line Sept 3rd, 2020.","DOI":"10.1016\/j.addr.2020.08.013"},{"key":"2043_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semcdb.2014.12.003","volume":"38","author":"JB Dixon","year":"2015","unstructured":"Dixon JB, Weiler MJ. Bridging the divide between pathogenesis and detection in lymphedema. Semin Cell Dev Biol. 2015;38:75\u201382.","journal-title":"Semin Cell Dev Biol"},{"key":"2043_CR35","doi-asserted-by":"crossref","unstructured":"Lu IM, Dixon JB. Assessment of upper extremity swelling among breast cancer survivors with a commercial infrared sensor. Lymphatic Res Biology. 2019.","DOI":"10.1089\/lrb.2018.0010"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-02043-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-020-02043-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-02043-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T19:20:58Z","timestamp":1635276058000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-020-02043-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2043"],"URL":"https:\/\/doi.org\/10.1186\/s12957-020-02043-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-42726\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-42726\/v2","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"20 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Study approval was obtained from the Institutional Review Boards of both Emory University (IRB00084299) and Georgia Institute of Technology (H16120). Patients provided informed written consent for enrollment and agreed to any use of their data for publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Part of the consent form included a statement about \u201csharing data with other researchers.\u201d Patients also understood and signed in the consent document that \u201cthe study results may be used to help others in the future and may find a better way to detect lymphedema at an earlier stage than our current methods currently do.\u201d Finally, the consent document (signed by the patient) stated that \u201cthe patient\u2019s name and other identifying information will not appear when we present or publish the study results.\u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Three of the authors on this paper have pertinent financial interests to disclose. J. Brandon Dixon and Michael J. Weiler invented the LymphaTech technology used in this study and they are eligible to receive royalties under the license agreement with Lymphatech. Dr. Dixon, Dr. Weiler, and Mr. Nathan D. Frank own equity in LymphaTech and Dr. Dixon serves as a scientific advisor to the company. The remaining authors (BW, IL, LK, JB, PS, JO, KB, ASL, and SGM) declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}